ft 19 oct 94 intern compani news genentech advanc 116 dollar 33 6m genentech us bio technolog compani buck trend bad news sector 116 per cent rise net incom third quarter dollar 33 6m 28 cent share compani attribut much growth latest product pulmozyn treat cystic fibrosi monday share two smaller biotech compani gensia pharmaceut procyt halv news new product fail clinic trial howev mr kirk raab chairman said import clinic develop progress quarter help us maintain rate growth compani said sale pulmozyn third quarter market dollar 21m compar dollar 18 7m second quarter drug launch franc germani quarter sell 18 countri sale activas use dissolv blood clot dollar 65 1m dollar 63 5m howev sale genentech two human growth hormon product protropin nutropin dollar 54 6m dollar 55 4m group revenu quarter dollar 193 8m increas 17 per cent research develop expenditur dollar 73 2m dollar 72 3m 38 per cent revenu genentech said expect govern investig past market method would materi impact compani share fell dollar 1 8 close dollar 51 1 8